Free Trial

Acumen Pharmaceuticals (ABOS) Insider Trading & Ownership

Acumen Pharmaceuticals logo
$2.47 -0.10 (-3.89%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$2.50 +0.03 (+1.38%)
As of 05/7/2026 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$285.06K
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABOS Insider Buying and Selling by Quarter

Acumen Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/22/2026
Daniel Joseph Oconnell
CEO
Sell2,689$1.88$5,055.32  
1/22/2026
Eric Siemers
Insider
Sell895$1.82$1,628.90  
1/22/2026
Matt Zuga
CFO
Sell1,687$1.86$3,137.82  
1/22/2026
Russell Barton
COO
Sell462$1.84$850.08  
1/21/2026
Daniel Joseph Oconnell
CEO
Sell9,346$1.81$16,916.26  
1/21/2026
Eric Siemers
Insider
Sell2,331$1.80$4,195.80  
1/21/2026
Matt Zuga
CFO
Sell2,473$1.81$4,476.13  
1/21/2026
Russell Barton
COO
Sell2,315$1.81$4,190.15  
1/12/2026
Daniel Joseph Oconnell
CEO
Sell5,388$1.73$9,321.24  
1/9/2026
Daniel Joseph Oconnell
CEO
Sell12,941$1.76$22,776.16  
1/8/2026
Daniel Joseph Oconnell
CEO
Sell8,143$1.82$14,820.26  
1/8/2026
James J Doherty
Insider
Sell6,467$1.82$11,769.94  
1/8/2026
Matt Zuga
CFO
Sell6,888$1.82$12,536.16  
1/8/2026
Russell Barton
COO
Sell3,530$1.86$6,565.80  
1/7/2026
Daniel Joseph Oconnell
CEO
Sell37,755$1.99$75,132.45  
1/7/2026
James J Doherty
Insider
Sell1,700$1.99$3,383.00  
1/7/2026
Matt Zuga
CFO
Sell5,805$1.99$11,551.95  
1/7/2026
Russell Barton
COO
Sell1,700$1.99$3,383.00  
1/6/2026
Daniel Joseph Oconnell
CEO
Sell5,102$1.97$10,050.94  
1/6/2026
Eric Siemers
Insider
Sell6,834$1.97$13,462.98  
1/6/2026
Matt Zuga
CFO
Sell5,100$1.97$10,047.00  
1/6/2026
Russell Barton
COO
Sell3,618$1.97$7,127.46  
1/5/2026
Daniel Joseph Oconnell
CEO
Sell4,649$1.97$9,158.53  
1/5/2026
Eric Siemers
Insider
Sell4,000$1.96$7,840.00  
1/5/2026
Matt Zuga
CFO
Sell4,000$1.96$7,840.00  
1/5/2026
Russell Barton
COO
Sell4,000$1.96$7,840.00  
(Data available from 1/1/2013 forward)

ABOS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Acumen Pharmaceuticals includes Daniel Joseph Oconnell, Derek M Meisner, Eric Siemers, James J Doherty, Jeffrey L. Ives, Matt Zuga, Ra Capital Management, L.P., and Russell Barton. Learn more on insiders at ABOS.

9.30% of Acumen Pharmaceuticals stock is owned by insiders. Learn more on ABOS's insider holdings.

The following insiders have sold ABOS shares in the last 24 months: Daniel Joseph Oconnell ($271,206.89), Eric Siemers ($52,335.04), James J Doherty ($15,152.94), Matt Zuga ($130,635.30), and Russell Barton ($48,850.99).

Insiders have sold a total of 281,344 Acumen Pharmaceuticals shares in the last 24 months for a total of $518,181.16 sold.



This page (NASDAQ:ABOS) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners